SMTI Stock Summary and Trading Ideas (Sanara Medtech | NASDAQ:SMTI)

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Sanara Medtech trades on the NASDAQ stock market under the symbol SMTI.

As of January 22, 2026, SMTI stock price declined to $22.25 with 47,794 million shares trading.

SMTI has a beta of 1.16, meaning it tends to be more sensitive to market movements. SMTI has a correlation of 0.14 to the broad based SPY ETF.

SMTI has a market cap of $198.82 million. This is considered a Micro Cap stock.

Last quarter Sanara Medtech reported $26 million in Revenue and $.09 earnings per share. This fell short of revenue expectation by $-301,000 and exceeded earnings estimates by $.32.

In the last 3 years, SMTI traded as high as $50.18 and as low as $18.90.

The top ETF exchange traded funds that SMTI belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

SMTI has underperformed the market in the last year with a price return of -34.6% while the SPY ETF gained +15.5%. SMTI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.7% and -8.8%, respectively, while the SPY returned +2.9% and -0.1%, respectively.

SMTI support price is $21.91 and resistance is $23.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SMTI shares will trade within this expected range on the day.